# Open Orphan Notice of results, analyst briefing and investor presentation

- Link: https://www.directorstalkinterviews.com/open-orphan-notice-of-results-analyst-briefing-and-investor-presentation/4121021466
- Published: 2021-09-09T07:14:11+01:00
- Author: Giles

**Open Orphan plc** ([LON:ORPH](https://www.directorstalkinterviews.com/company/open-orphan-plc/orph.l)),
a rapidly growing specialist contract research organisation (CRO) and world leader
in vaccine and antiviral testing using human challenge clinical trials, announced
that its interim results for the six-month period ended 30 June 2021 will be released
on Monday, 20 September 2021.

**Analyst Briefing**

A briefing open to analysts will take place remotely via video conference call on
Monday 20 September at 9.30am (BST). If you would like the details of this call,
please contact Walbrook PR on openorphan@walbrookpr.com.

**Investor Presentation**

Cathal Friel, Executive Chairman, and Leo Toole, Chief Financial Officer, will provide
a live presentation relating to the interim results via the Investor Meet Company
platform on Monday, 20 September 2021 at 6.00pm (BST).

The presentation is open to all existing and potential shareholders. Questions can
be submitted pre-event via your Investor Meet Company dashboard up until 9am the
day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Open Orphan
plc via:

[https://www.investormeetcompany.com/open-orphan-plc/register-investor](https://www.investormeetcompany.com/open-orphan-plc/register-investor)

Investors who already follow Open Orphan plc on the Investor Meet Company platform
will automatically be invited.

Share on:
